A research team at UCLA has developed a deep learning-powered chemiluminescence vertical flow assay (CL-VFA) that brings ...

The rate of cardiac injury as determined by cTnI in this study was 19%. In trying to identify any factors that may contribute to an overestimation of cardiac injury, we consider the use of cTnI ...

Cardiac troponins are a group of markers used to predict the risk of heart disease. However, it is not well understood how controlling blood pressure affects levels of troponin I and whether the ...

The ability to diagnose MI was better with troponin I, but T better predicted mortality. Both tests have strengths, ...

A bracelet-like device that measures levels of troponin-I in the blood could provide a more efficient way of detecting a heart attack, according to US researchers. The wearable developed by RCE ...

The researchers have designed a paper-based vertical flow assay (VFA). It detects cardiac troponin I (cTnI), a protein ...

The following is a summary of “Impact of impaired renal function on kinetics of high-sensitive cardiac troponin following ...

Survey conducted by YouGov commissioned by Siemens Healthineers offers a pulse check on Americans’ concerns about heart attacks, risk awareness ...

Switching from a conventional to a high-sensitivity cardiac troponin I assay in emergency departments is associated with a reduction in both mortality at 1 year and new admissions for myocardial ...

Cardiac enzymes ― also known as cardiac biomarkers ― include myoglobin, troponin and creatine kinase. Historically, lactate dehydrogenase, or LDH, was also used but is non-specific.

New data from US centers suggest some overtesting in patients without chest pain, and undertesting in those who do.

The following is a summary of “Correlation between high-sensitivity cardiac troponin levels in diabetic patients’ serum and lower limb lesions: based on NHANES data,” published in the January 2025 ...